Oxidized LDL drives endothelial activation and foam cell formation, amplifying atherosclerosis.

The transformation of low-density lipoprotein (LDL) into its oxidized form (ox-LDL) is a critical initiating and propagating event in the development of atherosclerosis, serving as a potent pro-inflammatory stimulus within the vessel wall.

Endothelial activation mechanisms

Ox-LDL serves as a primary ligand for the lectin-like oxidized LDL receptor-1 (LOX-1) on endothelial cells. This binding initiates a robust signaling cascade involving NADPH oxidase (NOX4) and reactive oxygen species (ROS) production, which activates the p38 MAPK and NF-κB pathways. The resulting transcriptional activity upregulates key adhesion molecules, specifically vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1). These proteins facilitate the recruitment and adhesion of circulating monocytes to the arterial intima, while simultaneously reducing nitric oxide bioavailability through ROS-mediated scavenging.

Macrophage uptake and foam cell formation

Unlike native LDL receptors, the scavenger receptors used by macrophages—primarily CD36 and SR-A1—are not subject to feedback inhibition. This allows for the unregulated internalization of ox-LDL. Once inside the lysosome, cholesteryl esters are hydrolyzed and subsequently re-esterified by Acyl-CoA:cholesterol acyltransferase 1 (ACAT1) into lipid droplets. This massive intracellular lipid accumulation morphologically transforms macrophages into foam cells, the hallmark of the fatty streak in early atherosclerosis.

Amplification of vascular inflammation

The presence of ox-LDL and the resulting cholesterol crystals within foam cells activate the NLRP3 inflammasome. This leads to the maturation of caspase-1 and the release of pro-inflammatory cytokines IL-1β and IL-18. This inflammatory environment further accelerates plaque growth and instability. Longitudinal data, such as from the PESA cohort, confirm that circulating ox-LDL levels independently predict global plaque volume progression, underscoring its role as a driver of clinical disease.

Bottom line

Oxidized LDL is a foundational driver of atherosclerosis, directly triggering endothelial activation via LOX-1 signaling and promoting unregulated macrophage lipid uptake to form foam cells. This cycle sustains a pro-inflammatory microenvironment that accelerates plaque progression and vascular damage.